凯卮
Lv64
1890 积分
2022-02-28 加入
-
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras
14天前
已完结
-
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
24天前
已完结
-
Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
24天前
已完结
-
Unraveling the future: innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy
24天前
已完结
-
Discovery of Potent and Selective Covalent Inhibitors of HER2WT and HER2YVMA
24天前
已完结
-
Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases
24天前
已完结
-
Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino [2,3-f]quinazolin derivatives as EGFR-TKIs
24天前
已完结
-
Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases
24天前
已完结
-
A Medicinal Chemistry Perspective on FDA-Approved Small Molecule Drugs with a Covalent Mechanism of Action
3个月前
已完结
-
Discovery of Potent, Highly Selective, and Efficacious SMARCA2 Degraders
3个月前
已完结